INDV:NASDAQ
Indivior Pharmaceuticals Inc
$35.84
arrow_upward
+1.09%(+0.38) 1D
Oct 9, 3:44:54 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
$35.45
High
$36.14
Low
$35.21
Mkt. cap
4.23B
Avg. vol.
2.02M
Volume
575.67K
P/E ratio
12.90
52-wk high
$42.81
52-wk low
$23.14
EPS
$2.78
Beta
1.10
Shares outstanding
118.03M
No. of employees
833
Open
$35.45
High
$36.14
Low
$35.21
Mkt. cap
4.23B
Avg. vol.
2.02M
Volume
575.67K
P/E ratio
12.90
52-wk high
$42.81
52-wk low
$23.14
EPS
$2.78
Beta
1.10
Shares outstanding
118.03M
No. of employees
833
News stories
From web sources and news partners
Investing.com South Africa
·
2 days ago
Form 4 INDIVIOR PHARMACEUTICALS For: 6 October By Investing.com
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc
CEOMark Crossley
Employees833
FoundedSep 26, 2014
Headquarters-
SectorPharmaceutical industry
Websiteindivior.com